Suchergebnisse - David Tougeron
- Treffer 1 - 20 von 58
- Zur nächsten Seite
-
1
-
2
ABCB4/MDR3 gene mutations and cholangiocarcinomas von David Tougeron, Ginette Fotsing, Véronique Barbu, Michel Beauchant
Veröffentlicht 2012Carta -
3
Irreversible electroporation and electrochemotherapy in oncology: State of the art von Jean‐Pierre Tasu, David Tougeron, Marie‐Pierre Rols
Veröffentlicht 2022Revisão -
4
Aspirin and Colorectal Cancer: Back to the Future von David Tougeron, Dan Sha, Sashidhar Manthravadi, Frank A. Sinicrope
Veröffentlicht 2013Revisão -
5
-
6
-
7
-
8
-
9
-
10
Proof of concept and design of an externally controlled trial for patients with gastro-enteropancreatic neuroendocrine carcinomas based on the randomized phase II BEVANEC trial von S. Ganame, T. Walter, A. Durand, Astrid Lièvre, David Tougeron, Jean–Yves Scoazec, E. Baudin, C. Lepage, Olayidé Boussari, Julien Hadoux
Veröffentlicht 2025Artigo -
11
Second‐line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first‐line platinum‐b... von Aziz Zaanan, Mélanie Gauthier, David Malka, Christophe Locher, Jean‐Marc Gornet, Anne Thirot‐Bidault, David Tougeron, Julien Taı̈eb, Franck Bonnetain, Thomas Aparicio
Veröffentlicht 2010Artigo -
12
Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer von David Tougeron, Thierry Lecomte, Jean‐Christophe Pagès, Claire Villalva, Christine Collin, Aurélie Ferru, J.M. Tourani, Christine Silvain, P. Levillain, L. Karayan-Tapon
Veröffentlicht 2013Artigo -
13
Mutation‐specific antibody detects mutant BRAF<sup>V600E</sup> protein expression in human colon carcinomas von Frank A. Sinicrope, Thomas C. Smyrk, David Tougeron, Stephen N. Thibodeau, Shalini Singh, Andrea Murányi, Kandavel Shanmugam, Thomas M. Grogan, Steven R. Alberts, Qian Shi
Veröffentlicht 2013Artigo -
14
Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor von Louis de Mestier, Thomas Walter, Camille Evrard, Paul de Boissieu, Olivia Hentic, Jérôme Cros, David Tougeron, Catherine Lombard‐Bohas, Vinciane Rebours, Pascal Hammel, Philippe Ruszniewski
Veröffentlicht 2019Artigo -
15
COVID-19 lockdown-related treatment modifications did not impact the outcome of digestive cancers: the Clin-COVIDICA prospective study von Violaine Randrian, Amale Dhimene, Armelle Pillet, Camille Evrard, Rayan Elfadel, Claire Boyer, Astrid Guyot d’Asnières de Salins, Isabelle Ingrand, Aurélie Ferru, Laetitia Rouleau, David Tougeron
Veröffentlicht 2025Artigo -
16
Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study von Maëva Salimon, Caroline Prieux‐Klotz, David Tougeron, Vincent Hautefeuille, Morgane Caulet, Jérôme Gournay, Tamara Matysiak‐Budnik, Jaafar Bennouna, Manuela Tiako Meyo, Thierry Lecomte, Aziz Zaanan, Yann Touchefeu
Veröffentlicht 2017Artigo -
17
Usefulness of the Serum Carcinoembryonic Antigen Kinetic for Chemotherapy Monitoring in Patients With Unresectable Metastasis of Colorectal Cancer von Isabelle Iwanicki–Caron, Frédéric Di Fiore, Isabelle Roque, Emilie Astruc, Monica Stetiu, A. Duclos, David Tougeron, Sandrine Saillard, S. Thureau, Jacques Bénichou, B Paillot, J P Basuyau, Pierre Michel
Veröffentlicht 2008Artigo -
18
<i>KRAS</i> Codon 12 and 13 Mutations in Relation to Disease-Free Survival in <i>BRAF</i>–Wild-Type Stage III Colon Cancers from an Adjuvant Chemotherapy Trial (N0147 Alliance) von Harry H. Yoon, David Tougeron, Qian Shi, Steven R. Alberts, Michelle R. Mahoney, Garth D. Nelson, Suresh Nair, Stephen N. Thibodeau, Richard M. Goldberg, Daniel J. Sargent, Frank A. Sinicrope
Veröffentlicht 2014Artigo -
19
Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter stu... von Antoine Adenis, Christelle de la Fouchardière, Bernard Paule, Pascal Burtin, David Tougeron, Jennifer Wallet, Louis-Marie Dourthe, Pierre-Luc Etienne, Laurent Mineur, Stéphanie Clisant, Jean-Marc Phélip, Andrew Kramar, Thierry André
Veröffentlicht 2016Artigo -
20
Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR) von Jean-Marc Phélip, David Tougeron, David Léonard, Léonor Benhaïm, G. Désolneux, Aurélien Dupré, Pierre Michel, Christophe Penna, Christophe Tournigand, Christophe Louvet, Niki Christou, P. Chevallier, Anthony Dohan, Benoı̂t Rousseau, Olivier Bouché
Veröffentlicht 2019Revisão
Suchwerkzeuge:
Ähnliche Schlagworte
Medicine
Internal medicine
Cancer
Oncology
Colorectal cancer
Chemotherapy
Biology
Gene
Cancer research
Gastroenterology
Surgery
Allele
Microsatellite
Microsatellite instability
Immunotherapy
Clinical endpoint
Genetics
Biochemistry
Gemcitabine
Irinotecan
Phases of clinical research
Randomized controlled trial
Chemistry
Clinical trial
Oxaliplatin
Adverse effect
Cohort
Confidence interval
Environmental health
Nivolumab